Tag Archives: pharmacy

Elderly Passed by the Italian Covid-19 Vaccination, and More Died | Instant News

ROME – Thousands of people have died each week from Covid-19 in Italy, one of the highest number and death rates per capita in the West.

One factor, according to the Italian government itself: For weeks, Italy has been slow to vaccinate the elderly. While national authorities prioritize the elderly and those in nursing homes with frontline health workers, regional authorities have given many of the injections to younger workers.

It was such a contrast to which England vaccination of the oldest age group first has contributed to the sharp drop in deaths from Covid-19.

In the last two weeks of March, Italy reported 102 deaths from Covid-19 for every one million population, compared to 47 in Spain, 28 in Germany and 11 in the UK At the end of March, people aged 70 or over represented 86 years of the 107,000 deaths. in Italy which was confirmed due to Covid-19.

“If we had vaccinated those over 70 or 75 from the start, we would have avoided so many deaths,” said Antonella Viola, a virologist at the University of Padua.


image source

Biocon s Arm Receives GMP Certificate of Compliance from UK Health Regulator MHRA For Bengaluru Facilities | Instant News

The certificate, which covers the manufacture and packaging of tablets and capsules in the non-potent and potent blocks of the facility, was issued based on a remote inspection of the week of March 22, 2021.

Biotech firm Biocon on Monday said its subsidiary Biocon Pharma had received a Good Manufacturing Practices (GMP) compliance certificate from UK health regulator MHRA for its Bengaluru facility.

‘Biocon Pharma Limited, a wholly owned subsidiary of Biocon Limited, has received a Good Manufacturing Practice (GMP) certificate of compliance from the Medicines and Healthcare Products Regulatory Agency (MHRA), UK (UK), for its manufacturing facility at Biocon Park in Bengaluru,’ said Biocon in the regulatory filing.

The certificate, which covers the manufacture and packaging of tablets and capsules in weak and robust facility blocks, was issued based on remote inspection in the week of March 22, 2021, following travel restrictions amid COVID-19. , the company added.

Biocon shares are trading 0.08 percent lower at Rs 419.95 each on BSE.



image source

WorldView: UK restricts use of the AstraZeneca COVID-19 vaccine; Myanmar Ambassador to UK locked out of embassy | Instant News

WorldView: UK restricts use of the AstraZeneca COVID-19 vaccine; Myanmar Ambassador to UK locked out of embassy – CBS News

Watch CBSN Live

The United Kingdom is dialing back the use of AstraZeneca COVID-19 vaccine for people younger than 30. Myanmar’s ambassador in London spent in the night in his car after he says he was locked out out of the embassy amid ongoing fallout from the country’s military coup. CBS News foreign correspondent Roxana Saberi joins CBSN AM with these stories and more.

Be the first to know

Get browser notifications for breaking news, live events, and exclusive reporting.


image source

The PRA remote patient monitoring platform was selected by Merck KGaA, Darmstadt, Germany to work in combination with a human growth hormone treatment system. Nasdaq: PRAH | Instant News

RALEIGH, NC, April 07, 2021 (GLOBE NEWSWIRE) – PRA Health Sciences (NASDAQ: PRAH) today announced that Merck KGaA, Darmstadt, Germany, known in the United States as EMD Serono, chose the PRA remote patient monitoring platform for work in combination with the human growth hormone (HGH) treatment system. Under this agreement, the PRA remote patient monitoring platform supports Merck KGaA, Darmstadt, Germany’s HGH treatment system, including growlinkTM, a mobile app for patients prescribed HGH treatment, and easypod┬« Connect, a secure platform for health care professionals (HCP) in the endocrinology field to monitor patient adherence, review injection history, and share information about the progress of patients with growth hormone disorder.

“Patients and payers expect us to offer new technologies, such as treatment support applications, with the highest levels of privacy and data security,” said Andre Musto, Senior Vice President and Head of Cardiovascular Metabolism & Endocrinology, Merck KGaA, Darmstadt, Germany. “With growlink and easypod Connect, supported by the PRA remote patient monitoring platform, we can offer patients innovative tools to help manage their condition and assure payers of the effective use of care while fully respecting the privacy and security of their data.”

Human growth hormone treatment is often prescribed for children and adolescents with growth hormone deficiency, a condition that affects an estimated 1: 4,000 to 1: 10,000 children1 each year in the US Despite the prevalence of growth hormone deficiency and treatment options, one of the biggest challenges is ensuring patient adherence to the regimen. Adding this layer of technology to HGH treatments facilitates better patient engagement, helps healthcare professionals make better use of patient visits, and ensures treatment is carried out regularly and at the right dose, optimizing treatment outcomes and encouraging payer trust.

In the real world, HCP will use easypod Connect to invite patients to download the mobile app, growlink. Then the patient downloads the mobile application, signs the eConsent form in the application, and synchronizes the application with Merck KGaA, Darmstadt, the German HGH injector medical device, easypod. The device is capable of self-adjusting the appropriate HGH dosage based on treatment protocols. The four-part system – Merck KGaA, Darmstadt, German mobile app (growlink), connected device (easypod), and the HCP platform (easypod Connect) supported by PRA remote patient monitoring technology – allows HCP to see an accurate picture of patient adherence height, weight, and other outcomes while offering patients a more comfortable way to follow a treatment regimen and manage their condition.

“For many years, PRA has focused on designing an end-to-end digital health platform that supports the delivery of mobile health services, such as remote patient monitoring,” said Kent Thoelke, Executive Vice President and Chief Scientific Officer, PRA Health Sciences. “Our collaboration with Merck KGaA, Darmstadt, Germany to support growlink and easypod Connect is an example of how the industry is growing with patients at the center of our innovation.”

PRA organizes a webinar called, How Digital Therapy and Remote Patient Monitoring Can Drive Differentiation of Pharmaceutical Products, to help create differentiation. Access today’s webinar replay.

For more information on PRA remote patient monitoring solutions, visit www.prahs.com.

1 Stanley T. Diagnosis of Growth Hormone Deficiency in Children. HHS Public Access. Available in https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3279941/

About PRA Health Sciences

PRA Health Sciences is one of the world’s leading global contract research organizations by revenue, providing clinical development services and data outsourcing solutions for the biotechnology and pharmaceutical industries. PRA’s global clinical development platform includes more than 75 offices in North America, Europe, Asia, Latin America, Africa, Australia and the Middle East, as well as more than 19,000 employees worldwide. Since 2000, PRA has participated in approximately 4,000 clinical trials worldwide. In addition, PRA has participated in important or supportive trials that resulted in the US Food and Drug Administration or international regulatory approvals for more than 95 drugs. To learn more about PRA, please visit www.prahs.com.

INVESTOR QUESTIONS: [email protected]

MEDIA QUESTION: Laurie Hurst, Sr. Director of Communications and Public Relations
[email protected] | +1 (919) 786-8435


image source

Indigenous Australians are Skeptical About Covid-19 Vaccines, and They’re Hard to Reach | Instant News

SYDNEY – To reach indigenous clans in northern Australia, vaccinators must pass through monsoon rains which can make airplanes and waterways infested with crocodiles. Once they reach the community, they face another formidable challenge in convincing the group to take fire.

First Nations like the people of East Arnhem Land – more than 600 miles by road from the nearby city of Darwin and bastions of traditional Aboriginal culture – are next in line Australian vaccination program which started last month and focuses on prioritizing health and other workers on the front lines to keep Covid-19 out of the country.

In many ways, vaccination programs are a litmus test for countries with large indigenous groups who feel marginalized and distrust government policies. Nearly 150,000 indigenous Australians lived in remote areas in 2016, according to the latest available government data. In East Arnhem Land, the life expectancy is around 50 years and half of Aboriginal children experience severe hearing, lung or other health problems by age 4.

“What we hear now is probably 50-75% going to say no,” said Eddie Mulholland, chief executive of Miwatj Health Aboriginal Corp., an indigenous community controlled primary health service for about 8,000 people across East Arnhem Land.

Concern rose among indigenous Australians after it was reported rare cases of blood clots in people in Europe who have received the Covid-19 injection developed by AstraZeneca PLC and the University of Oxford, although regulators have found no link between blood clots and vaccines and recommend continued use.


image source